Phase II Study of the Safety and Efficacy of Temsirolimus in East Asian Patients with Advanced Renal Cell Carcinoma†

2012 ◽  
Vol 42 (9) ◽  
pp. 836-844 ◽  
Author(s):  
Yan Sun ◽  
Sun Rha ◽  
Se-Hoon Lee ◽  
Jun Guo ◽  
Takeshi Ueda ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
East Asian ◽  
Advanced Renal Cell Carcinoma ◽  
Safety And Efficacy ◽  
Asian Patients ◽  
East Asian Patients

Subcutaneous Recombinant Interleukin-2 and a-Interferon in Patients with Advanced Renal Cell Carcinoma: Results of a Multicenter Phase II Study

1993 ◽  
Vol 8 (4) ◽  
pp. 289-300 ◽  
Author(s):  
Jens Atzpodien ◽  
Hartmut Kirchner ◽  
Peter de Mulder ◽  
Heiner Bodenstein ◽  
Tim Olivera ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Interleukin 2 ◽  
Advanced Renal Cell Carcinoma ◽  
Multicenter Phase ◽  
Recombinant Interleukin 2

12 Phase II study of lutetium-177-labeled anti carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

2015 ◽  
Vol 14 (2) ◽  
pp. e12 ◽  
Author(s):  
C.H.J. Muselaers ◽  
T.J. Van Oostenbrugge ◽  
M.J. Boers-Sonderen ◽  
O.C. Boerman ◽  
I.M.E. Desar ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Monoclonal Antibody ◽  
Carbonic Anhydrase ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Carbonic Anhydrase Ix ◽  
Advanced Renal Cell Carcinoma

A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109

2005 ◽  
Vol 56 (1) ◽  
pp. 39-45 ◽  
Author(s):  
Peter J. Van Veldhuizen ◽  
James R. Faulkner ◽  
Primo N. Lara ◽  
Paul H. Gumerlock ◽  
J. Wendall. Goodwin ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma ◽  
Oncology Group ◽  
Southwest Oncology Group ◽  
Group Trial

Phase II study of interferon gamma (rIFN-G) and vinblastine(VBL) in patients with advanced renal cell carcinoma (RCC)

1997 ◽  
Vol 33 ◽  
pp. S42
Author(s):  
C. Bacoyiannis ◽  
M.A. Dimopoulos ◽  
C. Nicolaides ◽  
G. Aravantinos ◽  
N. Xiros ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Interferon Gamma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma

Rationale and Protocol of SOAP: A Phase II Study to Evaluate the Efficacy of Sorafenib as Second-Line Treatment after Pazopanib in Patients with Advanced Renal Cell Carcinoma

2014 ◽  
Vol 100 (6) ◽  
pp. e282-e285
Author(s):  
Roberto Iacovelli ◽  
Elena Verzoni ◽  
Paolo Grassi ◽  
Alessio Farcomeni ◽  
Filippo de Braud ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma ◽  
Line Treatment ◽  
Second Line

Phase II study of bevacizumab and everolimus (RAD001) in the treatment of advanced renal cell carcinoma (RCC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5010-5010 ◽  
Author(s):  
R. C. Whorf ◽  
J. D. Hainsworth ◽  
D. R. Spigel ◽  
D. A. Yardley ◽  
H. A. Burris ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma

Phase II study of PALA and AMSA in advanced renal cell carcinoma

1983 ◽  
Vol 6 (5) ◽  
pp. 555-560 ◽  
Author(s):  
Robert H. Earhart ◽  
Paul J. Elson ◽  
Susan N. Rosenthal ◽  
Richard G. Hahn ◽  
Robert E. Slayton
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma

A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma

1994 ◽  
Vol 12 (2) ◽  
pp. 137-141 ◽  
Author(s):  
Jordan Berlin ◽  
A. Christie King ◽  
Kendra Tutsch ◽  
John W. Findlay ◽  
Peter Kohler ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma

scholarly journals A Multi-Center, Middle East, Phase II Study of the Raf-Kinase Inhibitor Sorafenib in Patients with Advanced Renal Cell Carcinoma

2012 ◽  
Vol 23 ◽  
pp. ix288
Author(s):  
H.M. Khaled ◽  
H. Abdel Azim ◽  
E. Barsoum ◽  
G. Chahine ◽  
A. Shamseddine ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Middle East ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma ◽  
Raf Kinase
Sign in / Sign up

Export Citation Format

Share Document